前立腺がんバイオマーカーの世界市場（～2026年）

• 英文タイトル：Global Prostate Cancer Biomarker Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04385 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は前立腺がんバイオマーカーのグローバル市場について調査・分析したレポートです。種類別（尿、血液、血清）市場規模、用途別（病院、診療所、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別前立腺がんバイオマーカーの競争状況、市場シェア ・世界の前立腺がんバイオマーカー市場：種類別市場規模 2015年-2020年（尿、血液、血清） ・世界の前立腺がんバイオマーカー市場：種類別市場規模予測 2021年-2026年（尿、血液、血清） ・世界の前立腺がんバイオマーカー市場：用途別市場規模 2015年-2020年（病院、診療所、がん研究所） ・世界の前立腺がんバイオマーカー市場：用途別市場規模予測 2021年-2026年（病院、診療所、がん研究所） ・北米の前立腺がんバイオマーカー市場分析：米国、カナダ ・ヨーロッパの前立腺がんバイオマーカー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの前立腺がんバイオマーカー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の前立腺がんバイオマーカー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの前立腺がんバイオマーカー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Thermo Fisher Scientific、QIAGEN、Roche Diagnostics、Beckman Coulter、Myriad Genetics、Sanofi-Aventis、Pfizer、MDx Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.
The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer.

Market Analysis and Insights: Global Prostate Cancer Biomarker Market
The global Prostate Cancer Biomarker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Prostate Cancer Biomarker Scope and Market Size
Prostate Cancer Biomarker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Thermo Fisher Scientific
QIAGEN
Roche Diagnostics
Beckman Coulter
Myriad Genetics
Sanofi-Aventis
Pfizer
MDx Health

Market segment by Type, the product can be split into
Urine
Blood
Serum
Market segment by Application, split into
Hospitals
Clinics
Cancer Institutes

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate Cancer Biomarker Revenue
1.4 Market by Type
1.4.1 Global Prostate Cancer Biomarker Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Urine
1.4.3 Blood
1.4.4 Serum
1.5 Market by Application
1.5.1 Global Prostate Cancer Biomarker Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Prostate Cancer Biomarker Market Perspective (2015-2026)
2.2 Global Prostate Cancer Biomarker Growth Trends by Regions
2.2.1 Prostate Cancer Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prostate Cancer Biomarker Historic Market Share by Regions (2015-2020)
2.2.3 Prostate Cancer Biomarker Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Prostate Cancer Biomarker Market Growth Strategy
2.3.6 Primary Interviews with Key Prostate Cancer Biomarker Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Biomarker Players by Market Size
3.1.1 Global Top Prostate Cancer Biomarker Players by Revenue (2015-2020)
3.1.2 Global Prostate Cancer Biomarker Revenue Market Share by Players (2015-2020)
3.1.3 Global Prostate Cancer Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate Cancer Biomarker Market Concentration Ratio
3.2.1 Global Prostate Cancer Biomarker Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Biomarker Revenue in 2019
3.3 Prostate Cancer Biomarker Key Players Head office and Area Served
3.4 Key Players Prostate Cancer Biomarker Product Solution and Service
3.5 Date of Enter into Prostate Cancer Biomarker Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Prostate Cancer Biomarker Historic Market Size by Type (2015-2020)
4.2 Global Prostate Cancer Biomarker Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Prostate Cancer Biomarker Market Size by Application (2015-2020)
5.2 Global Prostate Cancer Biomarker Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Prostate Cancer Biomarker Market Size (2015-2020)
6.2 Prostate Cancer Biomarker Key Players in North America (2019-2020)
6.3 North America Prostate Cancer Biomarker Market Size by Type (2015-2020)
6.4 North America Prostate Cancer Biomarker Market Size by Application (2015-2020)

7 Europe
7.1 Europe Prostate Cancer Biomarker Market Size (2015-2020)
7.2 Prostate Cancer Biomarker Key Players in Europe (2019-2020)
7.3 Europe Prostate Cancer Biomarker Market Size by Type (2015-2020)
7.4 Europe Prostate Cancer Biomarker Market Size by Application (2015-2020)

8 China
8.1 China Prostate Cancer Biomarker Market Size (2015-2020)
8.2 Prostate Cancer Biomarker Key Players in China (2019-2020)
8.3 China Prostate Cancer Biomarker Market Size by Type (2015-2020)
8.4 China Prostate Cancer Biomarker Market Size by Application (2015-2020)

9 Japan
9.1 Japan Prostate Cancer Biomarker Market Size (2015-2020)
9.2 Prostate Cancer Biomarker Key Players in Japan (2019-2020)
9.3 Japan Prostate Cancer Biomarker Market Size by Type (2015-2020)
9.4 Japan Prostate Cancer Biomarker Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Prostate Cancer Biomarker Market Size (2015-2020)
10.2 Prostate Cancer Biomarker Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate Cancer Biomarker Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate Cancer Biomarker Market Size by Application (2015-2020)

11 India
11.1 India Prostate Cancer Biomarker Market Size (2015-2020)
11.2 Prostate Cancer Biomarker Key Players in India (2019-2020)
11.3 India Prostate Cancer Biomarker Market Size by Type (2015-2020)
11.4 India Prostate Cancer Biomarker Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Prostate Cancer Biomarker Market Size (2015-2020)
12.2 Prostate Cancer Biomarker Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate Cancer Biomarker Market Size by Type (2015-2020)
12.4 Central & South America Prostate Cancer Biomarker Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Details
13.1.2 Thermo Fisher Scientific Business Overview
13.1.3 Thermo Fisher Scientific Prostate Cancer Biomarker Introduction
13.1.4 Thermo Fisher Scientific Revenue in Prostate Cancer Biomarker Business (2015-2020))
13.1.5 Thermo Fisher Scientific Recent Development
13.2 QIAGEN
13.2.1 QIAGEN Company Details
13.2.2 QIAGEN Business Overview
13.2.3 QIAGEN Prostate Cancer Biomarker Introduction
13.2.4 QIAGEN Revenue in Prostate Cancer Biomarker Business (2015-2020)
13.2.5 QIAGEN Recent Development
13.3 Roche Diagnostics
13.3.1 Roche Diagnostics Company Details
13.3.2 Roche Diagnostics Business Overview
13.3.3 Roche Diagnostics Prostate Cancer Biomarker Introduction
13.3.4 Roche Diagnostics Revenue in Prostate Cancer Biomarker Business (2015-2020)
13.3.5 Roche Diagnostics Recent Development
13.4 Beckman Coulter
13.4.1 Beckman Coulter Company Details
13.4.2 Beckman Coulter Business Overview
13.4.3 Beckman Coulter Prostate Cancer Biomarker Introduction
13.4.4 Beckman Coulter Revenue in Prostate Cancer Biomarker Business (2015-2020)
13.4.5 Beckman Coulter Recent Development
13.5 Myriad Genetics
13.5.1 Myriad Genetics Company Details
13.5.2 Myriad Genetics Business Overview
13.5.3 Myriad Genetics Prostate Cancer Biomarker Introduction
13.5.4 Myriad Genetics Revenue in Prostate Cancer Biomarker Business (2015-2020)
13.5.5 Myriad Genetics Recent Development
13.6 Sanofi-Aventis
13.6.1 Sanofi-Aventis Company Details
13.6.2 Sanofi-Aventis Business Overview
13.6.3 Sanofi-Aventis Prostate Cancer Biomarker Introduction
13.6.4 Sanofi-Aventis Revenue in Prostate Cancer Biomarker Business (2015-2020)
13.6.5 Sanofi-Aventis Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Prostate Cancer Biomarker Introduction
13.7.4 Pfizer Revenue in Prostate Cancer Biomarker Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 MDx Health
13.8.1 MDx Health Company Details
13.8.2 MDx Health Business Overview
13.8.3 MDx Health Prostate Cancer Biomarker Introduction
13.8.4 MDx Health Revenue in Prostate Cancer Biomarker Business (2015-2020)
13.8.5 MDx Health Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Prostate Cancer Biomarker Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate Cancer Biomarker Revenue
Table 3. Ranking of Global Top Prostate Cancer Biomarker Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate Cancer Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Urine
Table 6. Key Players of Blood
Table 7. Key Players of Serum
Table 8. Global Prostate Cancer Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Prostate Cancer Biomarker Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Prostate Cancer Biomarker Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Prostate Cancer Biomarker Market Share by Regions (2015-2020)
Table 12. Global Prostate Cancer Biomarker Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Prostate Cancer Biomarker Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Prostate Cancer Biomarker Market Growth Strategy
Table 18. Main Points Interviewed from Key Prostate Cancer Biomarker Players
Table 19. Global Prostate Cancer Biomarker Revenue by Players (2015-2020) (Million US$)
Table 20. Global Prostate Cancer Biomarker Market Share by Players (2015-2020)
Table 21. Global Top Prostate Cancer Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Biomarker as of 2019)
Table 22. Global Prostate Cancer Biomarker by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Prostate Cancer Biomarker Product Solution and Service
Table 25. Date of Enter into Prostate Cancer Biomarker Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Prostate Cancer Biomarker Market Size by Type (2015-2020) (Million US$)
Table 28. Global Prostate Cancer Biomarker Market Size Share by Type (2015-2020)
Table 29. Global Prostate Cancer Biomarker Revenue Market Share by Type (2021-2026)
Table 30. Global Prostate Cancer Biomarker Market Size Share by Application (2015-2020)
Table 31. Global Prostate Cancer Biomarker Market Size by Application (2015-2020) (Million US$)
Table 32. Global Prostate Cancer Biomarker Market Size Share by Application (2021-2026)
Table 33. North America Key Players Prostate Cancer Biomarker Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Prostate Cancer Biomarker Market Share (2019-2020)
Table 35. North America Prostate Cancer Biomarker Market Size by Type (2015-2020) (Million US$)
Table 36. North America Prostate Cancer Biomarker Market Share by Type (2015-2020)
Table 37. North America Prostate Cancer Biomarker Market Size by Application (2015-2020) (Million US$)
Table 38. North America Prostate Cancer Biomarker Market Share by Application (2015-2020)
Table 39. Europe Key Players Prostate Cancer Biomarker Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Prostate Cancer Biomarker Market Share (2019-2020)
Table 41. Europe Prostate Cancer Biomarker Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Prostate Cancer Biomarker Market Share by Type (2015-2020)
Table 43. Europe Prostate Cancer Biomarker Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Prostate Cancer Biomarker Market Share by Application (2015-2020)
Table 45. China Key Players Prostate Cancer Biomarker Revenue (2019-2020) (Million US$)
Table 46. China Key Players Prostate Cancer Biomarker Market Share (2019-2020)
Table 47. China Prostate Cancer Biomarker Market Size by Type (2015-2020) (Million US$)
Table 48. China Prostate Cancer Biomarker Market Share by Type (2015-2020)
Table 49. China Prostate Cancer Biomarker Market Size by Application (2015-2020) (Million US$)
Table 50. China Prostate Cancer Biomarker Market Share by Application (2015-2020)
Table 51. Japan Key Players Prostate Cancer Biomarker Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Prostate Cancer Biomarker Market Share (2019-2020)
Table 53. Japan Prostate Cancer Biomarker Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Prostate Cancer Biomarker Market Share by Type (2015-2020)
Table 55. Japan Prostate Cancer Biomarker Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Prostate Cancer Biomarker Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Prostate Cancer Biomarker Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Prostate Cancer Biomarker Market Share (2019-2020)
Table 59. Southeast Asia Prostate Cancer Biomarker Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Prostate Cancer Biomarker Market Share by Type (2015-2020)
Table 61. Southeast Asia Prostate Cancer Biomarker Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Prostate Cancer Biomarker Market Share by Application (2015-2020)
Table 63. India Key Players Prostate Cancer Biomarker Revenue (2019-2020) (Million US$)
Table 64. India Key Players Prostate Cancer Biomarker Market Share (2019-2020)
Table 65. India Prostate Cancer Biomarker Market Size by Type (2015-2020) (Million US$)
Table 66. India Prostate Cancer Biomarker Market Share by Type (2015-2020)
Table 67. India Prostate Cancer Biomarker Market Size by Application (2015-2020) (Million US$)
Table 68. India Prostate Cancer Biomarker Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Prostate Cancer Biomarker Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Prostate Cancer Biomarker Market Share (2019-2020)
Table 71. Central & South America Prostate Cancer Biomarker Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Prostate Cancer Biomarker Market Share by Type (2015-2020)
Table 73. Central & South America Prostate Cancer Biomarker Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Prostate Cancer Biomarker Market Share by Application (2015-2020)
Table 75. Thermo Fisher Scientific Company Details
Table 76. Thermo Fisher Scientific Business Overview
Table 77. Thermo Fisher Scientific Product
Table 78. Thermo Fisher Scientific Revenue in Prostate Cancer Biomarker Business (2015-2020) (Million US$)
Table 79. Thermo Fisher Scientific Recent Development
Table 80. QIAGEN Company Details
Table 81. QIAGEN Business Overview
Table 82. QIAGEN Product
Table 83. QIAGEN Revenue in Prostate Cancer Biomarker Business (2015-2020) (Million US$)
Table 84. QIAGEN Recent Development
Table 85. Roche Diagnostics Company Details
Table 86. Roche Diagnostics Business Overview
Table 87. Roche Diagnostics Product
Table 88. Roche Diagnostics Revenue in Prostate Cancer Biomarker Business (2015-2020) (Million US$)
Table 89. Roche Diagnostics Recent Development
Table 90. Beckman Coulter Company Details
Table 91. Beckman Coulter Business Overview
Table 92. Beckman Coulter Product
Table 93. Beckman Coulter Revenue in Prostate Cancer Biomarker Business (2015-2020) (Million US$)
Table 94. Beckman Coulter Recent Development
Table 95. Myriad Genetics Company Details
Table 96. Myriad Genetics Business Overview
Table 97. Myriad Genetics Product
Table 98. Myriad Genetics Revenue in Prostate Cancer Biomarker Business (2015-2020) (Million US$)
Table 99. Myriad Genetics Recent Development
Table 100. Sanofi-Aventis Company Details
Table 101. Sanofi-Aventis Business Overview
Table 102. Sanofi-Aventis Product
Table 103. Sanofi-Aventis Revenue in Prostate Cancer Biomarker Business (2015-2020) (Million US$)
Table 104. Sanofi-Aventis Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Product
Table 108. Pfizer Revenue in Prostate Cancer Biomarker Business (2015-2020) (Million US$)
Table 109. Pfizer Recent Development
Table 110. MDx Health Business Overview
Table 111. MDx Health Product
Table 112. MDx Health Company Details
Table 113. MDx Health Revenue in Prostate Cancer Biomarker Business (2015-2020) (Million US$)
Table 114. MDx Health Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Biomarker Market Share by Type: 2020 VS 2026
Figure 2. Urine Features
Figure 3. Blood Features
Figure 4. Serum Features
Figure 5. Global Prostate Cancer Biomarker Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Cancer Institutes Case Studies
Figure 9. Prostate Cancer Biomarker Report Years Considered
Figure 10. Global Prostate Cancer Biomarker Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Prostate Cancer Biomarker Market Share by Regions: 2020 VS 2026
Figure 12. Global Prostate Cancer Biomarker Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Prostate Cancer Biomarker Market Share by Players in 2019
Figure 15. Global Top Prostate Cancer Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Biomarker as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Biomarker Revenue in 2019
Figure 17. North America Prostate Cancer Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Prostate Cancer Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Prostate Cancer Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Prostate Cancer Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Prostate Cancer Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Prostate Cancer Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Prostate Cancer Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

---